AKTX   $2.2  -1.79% Market Open

Akari Therapeutics PLC
Total Cash 4.18M
totalCashPerShare 0.0
EBITDA -18.08M
Total Debt 1.00M
quickRatio 0.476
currentRatio 0.578
Total Revenue
debtToEquity
Revenue/Share
ROA -1.7282699
ROE
grossProfits
freeCashflow -7.51M
operatingCashflow -15.80M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 60.98B
forwardPE
floatShares 12.78B
sharesOutstanding 12.14M
sharesShort 39.05K
sharesShortPriorMonth 39.03K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.38%
heldPercentInstitutions 0.01%
Short Ratio help_outline 2.26%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue -0.305
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -20.13M
trailingEps -2.99%
forwardEps -3.40%
enterpriseToEbitda -3.37K
lastDividendValue
lastDividendDate
currentQuarterEstimate 2Q 2021
institutionsCount 11
lastUpdated Oct. 16, 2024, 6:19 p.m.